返回

Extrinsic regulation of optic nerve regeneration

阅读量：10297
DOI：10.12419/es24071101
发布日期：2024-06-18
作者：
张琪 ,唐家辉 ,刘哲 ,吴彩清 ,刘灿瑛 ,吴思婷 ,卓业鸿 ,李轶擎
展开更多

关键词

retinal ganglion cells
optic nerve regeneration
myelin
glial scar
neuroinflammation
amacrine cells

摘要

Retinal ganglion cells (RGCs) extend through the optic nerve, connecting with neurons in visually related nuclei. Similar to most mature neurons in the central nervous system, once damaged, RGCs are unable to regenerate their axons and swiftly progress to cell death. In addition to cell-intrinsic mechanisms, extrinsic factors within the extracellular environment, notably glial and inflammatory cells, exert a pivotal role in modulating RGC neurodegeneration and regeneration. Moreover, burgeoning evidence suggests that retinal interneurons, specifically amacrine cells, exert a substantial influence on RGC survival and axon regeneration. In this review, we consolidate the present understanding of extrinsic factors implicated in RGC survival and axon regeneration, and deliberate on potential therapeutic strategies aimed at fostering optic nerve regeneration and restoring vision.

全文

HIGHLIGHTS

• The review emphasizes the role of extrinsic factors in regulating retinal ganglion cell (RGC) axon regeneration. Traditionally, glial cells and inflammation have been highlighted, but recent discoveries focus on retinal interneurons, specifically amacrine cells (ACs), as crucial regulators.
• Research methods have shifted to include investigation of the synaptic interactions between ACs and RGCs, offering new perspectives beyond traditional focus areas like glial scar inhibition and inflammatory response modulation.
• Modulating the inhibitory glial environment and managing inflammatory responses remain promising areas for intervention to enhance regenerative outcomes, while understanding the exact mechanism behind AC-mediated optic nerve injury will be crucial in designing effective treatments for optic nerve regeneration and restoring vision.

INTRODUCTION

       Retinal ganglion cells (RGCs) play a vital role in visual function, as their axons constitute the optic nerve, traversing from the retina through the optic chiasm to innervate brain nuclei.[1] The optic nerve’s extensive journey from the retina to the brain makes it susceptible to numerous injuries.[2] Similar to most mature neurons in the central nervous system (CNS), RGCs cannot regenerate their axons upon damaged, frequently causing lasting visual deficits or blindness. Apart from cell-intrinsic mechanisms within RGCs, their regenerative failure is also modulated by multiple extrinsic factors.[3] Consequently, modifying the extrinsic environment of RGCs has become a key area of focus in optic nerve regeneration research.
       Traditionally, glial and inflammatory cells have been regarded as the primary components of the extrinsic environment impacting optic nerve regeneration.[4-5] The glial environment, encompassing myelin and the glial scar, acts as a significant inhibitor of RGC axon regeneration, containing various inhibitory molecules derived from oligodendrocytes and reactive astrocytes.[5] Conversely, intraocular inflammation and its associated chemokines and neurotrophic factors are thought to stimulate RGCs to regenerate their axons after injury.[6] Recently, a novel concept has arisen, suggesting that the capacity of RGCs to regenerate axons is also affected by retinal interneurons within the extrinsic environment, particularly amacrine cells (ACs).[7] Unlike glial and inflammatory cells, ACs engage with RGCs through synaptic interactions.
       In this review, we consolidate current understanding of extrinsic factors that influence optic nerve regeneration and delve into related therapeutic approaches aimed at enhancing this critical process.

GLIAL ENVIRONMENT

 Myelin and Associated Inhibitors

       Myelin plays a pivotal role in axonal insulation, facilitating rapid electrical signal conduction, and providing metabolic support within the adult nervous system.[8] In the peripheral nervous system, Schwann cells are responsible for producing myelin and actively promoting axon regeneration after injury. Conversely, in the CNS, oligodendrocytes generate myelin barriers that impede axon regeneration by releasing myelin-associated inhibitors (MAIs), such as Nogo, myelin-associated glycoprotein (MAG), and oligodendrocyte-myelin glycoprotein (OMgp).[9-12] Although structurally distinct, these molecules share the capacity to bind two common receptors: Nogo receptor (NgR) and immunoglobulinlike receptor B (PirB).[13-14] NgR1, expressed by virtually all RGCs, forms a signaling complex with LINGO-1 and either p75NTR or TROY.[15-18] While NgR2 exhibits a stronger binding affinity for MAG compared to NgR1, NgR3 may act as a co-receptor.[19] The interaction of these molecules with receptors on RGC axons disrupts the actin cytoskeleton, causes growth cones collapses, and obstructs axon regeneration (Figure 1).
Figure 1 Schematic illustration of traditional extrinsic factors from glial and inflammatory cells that regulate optic nerve regeneration
MAIs, inhibitory molecules from glial scar, Ocm, and neurotrophic factors diversely regulate the post-injury regeneration of the optic nerve. BDNF, brain-derived neurotrophic factor; CNTF, ciliary neurotrophic factor; CSPGs, chondroitin sulfate proteoglycans; LIF, leukemia inhibitory factor; MAG, myelin-associated glycoprotein; Ocm, oncomodulin; OMgp, oligodendrocyte-myelin glycoprotein; Sema3A, semaphorin 3A.

       Genetic interventions aimed at MAIs have revealed that triple knockout mice (Nogo-A, MAG, OMgp) exhibit RGC axon regrowth post-injury, a phenomenon not observed in single or double knockouts, underscoring the prominent role of Nogo-A and the synergistic effects of MAG and OMgp.[20-21] Selective deletion of Nogo-A in oligodendrocytes, while maintaining its expression in RGCs, has been shown to foster axon regeneration.[22] Furthermore, immunoblocking MAIs with antibodies, particularly Nogo-A antibodies, enhances RGC axon regeneration.[23-24] Manipulating receptors has also yielded promising results. For example, NgR knockout promotes optic nerve regeneration, and AAV-mediated expression of a dominant-negative NgR stimulates axon regrowth.[25-26] The endogenous NgR antagonist, LOTUS, is being investigated as a potential therapeutic target due to its ability to block MAI binding and promotes regeneration.[27-28] Interfering with PirB activity, through genetic manipulation or antibody treatment, has been found to partially mitigate myelin inhibition.[29] A recent study demonstrated that PirB knockdown in RGCs can disrupt inhibitory signals from the glial environment, thereby inducing optic nerve regeneration.[30]
       In summary, myelin and its associated inhibitors pose significant barriers to axon regeneration wthin the CNS. By gaining insights into and targeting the molecular interactions between oligodendrocytes and RGCs, as well as modulating the receptors involved, it may be feasible to circumvent these inhibitory effects and foster optic nerve regeneration.

Glial Scar Forming at the Injury Sites

       After injury, the adult CNS promptly initiates reactive astrogliosis or glial scarring as a means of protecting and repairing tissue.[31] However, this response also establishes a chemical barrier that hampers axon regeneration. Astrocytes, which are pivotal in supporting synapse development and plasticity, are responsible for forming these glial scars and depositing inhibitory molecules such as tenascins, semaphorins, ephrins, and notably chondroitin sulfate proteoglycans (CSPGs).[32-35] These molecules attach to specific receptors on RGCs, thereby impeding regeneration (Figure 1). The primary receptors that mediate CSPG inhibition encompass the transmembrane protein PTPσ, LAR phosphatase, along with NgR1 and NgR3.[36] Neuropilin 1 and plexin A1 serve as co-receptors for Sema3A, triggering downstream signaling pathways that further inhibit regeneration.[37] Moreover, Integrin α9β1, a receptor that promotes neurite outgrowth and axon regeneration by binding to TN-C, is diminished or absent in the adult CNS following injury, thus nullifying TN-C’s regenerative effects.[38]
       Research has demonstrated that the enzyme chondroitinase ABC digests glycosaminoglycan side chains, effectively reducing CSPG inhibition and fostering RGC axon regeneration.[39] Genetic deletion of PTPσ and systemic administration of enoxaparin have also exhibited potential in augmenting axon regrowth.[40] Although intravitreal injection of anti-Sema3A antibodies has been observed to enhance RGC survival, its impact on axon regeneration is still being investigated. Nevertheless, miR-30b and Sema3A small interfering RNA have been proven to suppress Sema3A expression, significantly stimulating axon growth.[41-42] Studies on mice deficient in TN-C or TN-R, subjected to spinal cord injuries, have indicated increased axon penetration through the glial scar.[43] Furthermore, the re-expression of TN-C and the integrin activator kindlin-1 has been shown to promote axon regeneration in both the spinal cord and optic nerve.[44-45]
       Overall, by targeting the inhibitory molecules associated with glial scarring and combining these approaches with other therapeutic interventions, there is considerable potential to enhance optic nerve regeneration and restore visual function.

Controversial Role of Microglia

        Microglia, which originate from macrophages in the mammalian CNS, play a crucial role in maintaining physiological homeostasis and responding to pathological conditions. However, their function in CNS repair following injury remains paradoxical.[46] The question of whether cytokines and neurotrophic factors released by microglia promote or hinder optic nerve regeneration remains unresolved. The ambiguity may stem, in part, from difficulties in distinguishing microglia from other immune cells.[47] A recent study introduced a novel CSF1R inhibitor that can eliminate over 99% of microglia without impacting macrophages or other immune cells.[48] Notably, intravitreal administration of this inhibitor did not significantly alter RGC degeneration or axon regeneration after injury. Yet, when microglia and macrophages were co-depleted, a slight but statistically significant inhibition of optic nerve regeneration was observed.[49] This finding suggests that while microglia participate in macrophage recruitment and phagocytosis, they may not be pivotal for RGC degeneration and axon regeneration in the context of acute optic nerve injury.

 INFLAMMATION

       Intraocular inflammation, whether induced by lens injury or zymosan injection, has been shown to delay RGC degeneration and enhance axon regeneration beyond optic nerve lesions, exerting a significant impact on neurological outcomes.[50-51] Macrophages and neutrophils, which are key immune cells that accumulate at the site of injury, engage interactions with RGCs via cytokines and neurotrophic factors, thereby modulating the process of axon regeneration (Figure 1).

Macrophages

       Macrophages play a crucial role in converting the inhibitory environment at lesion sites into one that is conductive to regeneration.[52] Following lens injury or zymosan injection, increased macrophage levels are accompanied by the accumulation of oncomodulin (Ocm), a calcium-binding protein that is released by activated macrophages and neutrophils.[53] Ocm interacts with RGCs in a cAMP-dependent manner, functioning as a potent growth factor that promotes axon regeneration.[54-55] Combination treatments utilizing Ocm alongside cAMP analogs have been found to mimic the regenerative effects of inflammation, whereas antibodies targeting Ocm neutralize these beneficial effects.[55] Recently, armadillo-repeat protein C10 (ArmC10) has been identified as the high-affinity receptor for Ocm. Genetic deletion of ArmC10 has been shown to inhibit inflammation-induced axon regeneration in the injured optic nerves of mice.[56]

Neutrophils

       Neutrophils swiftly accumulate following injury, preceding the influx of macrophages in zymosan-induced intraocular inflammation, and are pivotal in promoting optic nerve regeneration. These cells exhibit elevated levels of Ocm, and their absense or neutralization with anti-Ocm intervention markedly diminishes regenerative effects, highlighting their essential collaboration with macrophages.[6] Inhibition studies implicate patternrecognition receptors as potential mediators of these effects.[57] Furthermore, the use of specific antibodies targeting distinct neutrophil subsets provide additional evidence for their contribution to axon regeneration.[58] A recently discovered subset of immature neutrophils has exhibited neuroprotective qualities, driving optic nerve regeneration in vivo, partially through the release of a blend of growth factors.[59] Moreover, a recent study demonstrated that transfer of IL-4/G-CSF-polarized bone marrow neutrophils into experimental models of optic nerve injury stimulates substantial axon regeneration.[60] Conversely, selective targeting of neutrophils with anti-Ly6G has also been found to safeguard the inflamed vasculature and augment RGC axon regeneration.[61]

Chemokines

       Chemokine CXCL12, also known as stromal cell–derived factor 1 (SDF1), functions as a chemoattractant for axonal growth cones within an inhibitory milieu, thereby hindering the distal regeneration of growth-stimulated axons in the optic nerve. Specific deletion of the receptor CXCR4 in RGCs mitigates abnormal axonal growth and enhances long-distance regeneration.[62] Conversely, another study revealed that SDF1 synergizes potently with Ocm treatment, fostering the regeneration of a greater number of RGC axons.[63] Additionally, other chemokines, including CXCL2 and CX3CL1, have demonstrated their ability to support RGC survival and axon regeneration by modulating glial activation and inflammation.[64-65]

Neurotrophic Factors

       Ciliary neurotrophic factor (CNTF) is a well-established and potent neurotrophic agent for treating optic nerve injury.[66] However, the administration of recombinant CNTF alone exhibits limited regenerative efficacy. It is noteworthy that the knockout of SOCS3 restores CNTF's regenerative potential.[67] Furthermore, AAV-mediated expression of CNTF promotes optic nerve regeneration independently through neuroinflammatory pathways that involving CCL5.[58] Recent advancements in CNTF delivery systems, such as the use of chitosan or thermosensitive hydrogels, have facilitated a steady and consistent release of CNTF, resulting in full-length optic nerve regeneration and, notably, visual function recovery.[62, 68] Additionally, leukemia inhibitory factor (LIF) synergizes with CNTF to enhance RGC survival and promote axon regeneration.[66] Conversely, brain-derived neurotrophic factor (BDNF) protects RGCs but attenuates inflammation-induced axon regeneration.[69]

RETINAL INTERNEURONS

       As previously discussed, the roles of glial and inflammatory cells in the context of optic nerve injury have been thoroughly investigated. However, another vital group of cells, the interneurons, which maintain close connections with RGCs, have been relatively overlooked. These interneurons interact primarily with RGCs via synapses, forming the intricate retinal circuits. In the mammalian retinal circuitry, photoreceptors convert light into neural signals, which they then transmit to interneurons. Within the outer plexiform layer, horizontal cells engage with photoreceptors, exerting feedback inhibition on photoreceptors and feedforward inhibition on bipolar cells (BCs).[70] In the inner plexiform layer, BCs establish excitatory synapses with over 40 distinct types of ganglion cells.[71] Various types of ACs modulate these synapses through both pre-synaptic and post-synaptic inhibition.
       ACs, as the primary inhibitory interneurons within the retinal circuit, diminish RGC activity by releasing inhibitory neurotransmitters such as glycine, gamma-aminobutyric acid (GABA), and dopamine.[72] Nearly all ACs form inhibitory synapses with RGCs and can be categorized into two types: glycinergic narrow-field and GABAergic wide-field. Unlike typical neurons, ACs utilize the same dendrites for both receiving and transmitting signals to BCs, RGCs, and other ACs.[70]

Amacrine Cells–Mediated Optic Nerve Regeneration

       To investigate the factors within the retina that influence the rapid decline of growth potential in neonatal RGCs, Goldberg and colleagues aged embryonic RGCs in culture, aligning their growth patterns with those of neonatal RGCs. Their findings revealed that embryonic RGCs do not inherently lose their growth capacity under these conditions. However, when these RGCs were aged within retinal explants or cultured with isolated ACs, their axon growth potential diminished significantly.[73] Furthermore, ACs were identified as crucial players in the proper patterning of RGC axon during development.[74] These studies revealed a contact-dependent mechanism through which ACs inhibit the growth of developing RGC axon in culture (Figure 2). While this conclusion merely skimmed the surface of the phenomenon, it hinted that this inhibition might encompass retinal interneurons apart beyond glial cells.

 

Figure 2 Schematic illustration of AC-mediated optic nerve regeneration 
ACs regulate optic nerve regeneration through contact inhibition, presynaptic Zn2+ release, and various neurotransmitters. AC, amacrine cell; RGC, retinal ganglion cell.

        A decade later, direct evidence emerged regarding AC-regulated optic nerve regeneration. Reports indicated that ionic zinc (Zn2+) accumulates in ACs processes promptly after optic nerve crush and continues to rise for the first 24 hours. Zn2+ is subsequently transferred to RGCs via synaptic vesicular release, thereby suppressing RGC survival and axon regeneration (Figure 2).[75] By genetically deleting the Zn2+ transporter 3 (ZnT-3) or chelation with TPEN, Zn2+ release from ACs is reduced, promoting optic nerve regeneration and maintaining RGCs survival for 3 months. Additionally, Zn2+ chelation exhibits a potent synergistic effect when combined with canonical pro-regenerative manipulations, such as Ptenknockout and Klf9 knockout.[75-76]
       Furthermore, a subsequent study revealed that ACs become hyperactive in response to RGC axon injury in adult mice. As the primary presynaptic source of inhibition for RGCs, this hyperactivity diminishes RGC electrical activity following injury. By preventing this AC-induced hyperinhibition—either through the overexpressing of inwardly rectifying K+channels or via intravitreal injections of a mixture containing GABA and glycine receptor blockers— RGC survival after ONC is enhanced, and modest axon regeneration is promoted (Figure 2).[77]
       A recent study has pinpointed a distinct AC subtype, dopaminergic ACs (DACs), which play a role in the pathogenesis of optic nerve injury and regulate optic nerve regeneration. Following optic nerve injury, DACs respond promptly by decreasing their neuronal activity and reducing retinal dopamine release. Stimulating DACs with levodopa administration elevates dopamine release, ultimately fostering optic nerve regeneration (Figure 2).[78] However, despite several theories summarizing the mechanisms underlying AC-RGC interactions in optic nerve regeneration, these mechanisms remain largely unknown.

Antagonistic Axon-Dendrite Interplay

       The first theory revolves around the antagonist interplay between axons and dendrites, proposing that dendritic synapses connecting adult RGCs to ACs hinder axon regeneration. In adult zebrafish, renowned for their ability to regenerate CNS axons, RGCs exhibit rapid synapse degeneration and dendrite retraction after optic nerve crush. Axon regeneration only commences following substantial dendrite shrinkage, with dendritic regrowth taking place once axons reconnect with target neurons in the optic tectum. This finding implies a competitive dynamic between axonal and dendritic processes.[79] Additional studies also suggest that impeding dendrite shrinkage obstructs axon regeneration. For instance, inhibiting mTOR with rapamycin shortly after ONC preserves synapses and dendrites but impedes axon regeneration. However, postponing rapamycin treatment until after synapse and dendrite deterioration has occurred does not impact regeneration, indicating that dendrite shrinkage may actually facilitate axon regrowth.[80]
       In mammals, although dendrite shrinkage may pave the way for axon regrowth, they typically fail to regenerate axons due to inhibitory surroundings. Signals emanating from ACs can redirect neonatal RGCs from an axon growth mode to a dendrite growth mode. Treatments with CNTF, cAMP analogs, or the Rho-GTPase inhibitor BA-210 enhance RGC survival and axon regeneration but result in abnormal dendritic structures.[81-83] In a DLK knockout background, severing dendrites promotes axon regeneration, and in C. elegans, axon regeneration is augmented when dendritomy accompanies axotomy.[84-85]
       Overall, the retraction of RGC dendrite from synaptic connections with interneurons appears to facilitate axon regeneration and nerve repair. Nevertheless, further research is required to substantiate this antagonistic interplay and the precise role of synaptic inhibition in the context of optic nerve regeneration.

Inhibitory Neurotransmitter

       The second theory emphasizes the significance of various neurotransmitters released by ACs, which may play a pivotal role in the pathophysiological mechanisms underlying optic nerve injury. Neurotransmitter diversity is crucial for the intricacy and functionality of neuronal communication. Within retinal circuits, RGC dendrites possess receptors for glycine, GABA-A, and dopamine, which convey inhibitory signals from ACs, whereas BC axon terminals harbor glycine and GABA-C receptors for AC-mediated inhibition.[86] These inhibitory neurotransmitters and their receptors represent potential therapeutic avenues in the aftermath of optic nerve injury.
       In the context of spinal cord injury, there is an elevation of aminoacidergic neurotransmitters (glycine, GABA, glutamate), with excessive glutamate and glycine contributing to excitotoxicity, while GABA fosters neuron survival and regeneration.[87-89] Although this phenomenon has been less explored in mammals and optic nerve injury, some evidence indicates that inhibitory neurotransmitters also influence regeneration. Following ONC, the adminstration of antagonists for inhibitory neurotransmitter receptors into the vitreous body enhances RGC responsiveness to growth factors and promotes axon regeneration, notably with IGF-1, owing to the preservation of IGF-1 receptors in RGC primary cilia.[77]
       RGC activity, modulated by neurotransmitters released from ACs, impacts their growth state. Studies have demonstrated that increased electrical activity enhances BDNF-induced axon outgrowth in immature RGCs.[90] Additionally, light stimulation or transcorneal electrical stimulation has been found to stimulate RGC axon regeneration.[91] When visual stimulation or chemogenetics are combined with mTOR activation, they can enhance complete optic nerve regeneration and partially restore visual functions and behaviors.[92-93] RGC activation and depolarization result in the inlux of Ca2+, initiating activity-dependent transcription and elevating cAMP levels. This process promotes the expression of growth-related genes and establishes a link between neuronal activity and regeneration.[94-95]
       In conclusion, further research is required to clarify the specific roles of neurotransmitters in optic nerve injury, including their protective or neurotoxic effects, the receptors they bind to, and their downstream signaling pathways.

Other Synaptic Vesicular Contents

       The third theory delves into other synaptic vesicular components, with a particular emphasis on Zn2+. Following ONC, Zn2+ levels surge in ACs and are subsequently transferred to RGCs through synaptic vesicular release. Eliminating ZnT-3, which diminishes Zn2+ accumulation within AC vesicles, has been shown to enhance axon regeneration.[75] Furthermore, the production of nitric oxide (NO) specific to ACs may aid in the accumulation of mobile Zn2+ in ACs after injury. Upon RGC axon injury, ACs exhibit hyperactive, resulting in Ca2+ influx and the subsequent production of NO production via NO synthetase activation.[96] This sequence generates reactive nitrogen species, leading to oxidative stress and the release of Zn2+ from metallothioneins, thereby elevating mobile Zn2+ levels in ACs.[97-98]

SUMMARY

       This review centers on the extrinsic regulation of optic nerve regeneration, with a focus on the intricate interactions between RGCs and their surrounding environment. While glial and inflammatory cells are well-recognized extrinsic factors that impact optic nerve regeneration, recent findings underscore the crucial role of ACs in regulating RGC survival and axon regeneration. Following optic nerve injury, ACs become hyperactivated, secreting inhibitory neurotransmitters and vesicular components such as zinc, which impede RGC regeneration. Several theories have been postulated to explain the mechanisms underlying AC-mediated optic nerve regeneration. Yet, the exact mechanism triggering AC hyperactivation immediately after RGC axon injury remains elusive. One hypothesis posits that post-injury dysregulation of Cl- gradients in interneurons initiates positive feedback loops between BCs and ACs, resulting in early AC hyperactivation.
       In conclusion, strategies targeting the interactions of AC-RGC, modulation of the inhibitory glial environment, and management of inflammatory responses present promising avenues for promoting optic nerve regeneration. This review synthesizes current understanding of these extrinsic factors and delves into potential interventions aimed at enhancing regenerative outcomes and restoring visual function.

Correction notice

None

Acknowledgement

Figures were created with BioRender.com.

Author Contributions

(Ⅰ) Conception and design: Qi Zhang and Yiqing Li
(Ⅱ) Administrative support: Yehong Zhuo and Yiqing Li
(Ⅲ) Provision of study materials or patients: Jiahui Tang, Zhe Liu, and Caiqing Wu
(Ⅳ) Collection and assembly of data: Siting Wu
(Ⅴ) Data analysis and interpretation: Canying Liu
(Ⅵ) Manuscript writing: All authors
(Ⅶ) Final approval of manuscript: All authors

Fundings

This work was supported by the National Natural Science Foundation of China (82471067 to Y.L.), Guangdong Basic and Applied Basic Research Foundation (2022A1515012168 to Y.L.), Science and Technology Program of Guangzhou (202201020492 to Y.L.), and Open Research Funds of the State Key Laboratory of Ophthalmology (2023KF01 to Y.L.).

Conflict of Interests

None of the authors has any conflicts of interest to disclose. All authors have declared in the completed the ICMJE uniform disclosure form.

Patient consent for publication

None

Ethical Statement

None

Provenance and Peer Review

This article was a standard submission to our journal. The article has undergone peer review with our anonymous review system.

Data Sharing Statement

None

Open Access Statement

This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license).


基金

1. This work was supported by the National Natural Science Foundation of China (82471067 to Y.L.), Guangdong Basic and Applied Basic Research Foundation (2022A1515012168 to Y.L.), Science and Technology Program of Guangzhou (202201020492 to Y.L.), and Open Research Funds of the State Key Laboratory of Ophthalmology (2023KF01 to Y.L.).

参考文献

1. Dhande OS, Stafford BK, Lim JH A, et al. Contributions of retinal ganglion cells to subcortical visual processing and behaviors. Annu Rev Vis Sci. 2015, 1: 291-328. DOI: 10.1146/annurev-vision-082114-035502.
2. Moore DL, Goldberg JL. Four steps to optic nerve regeneration. J Neuroophthalmol. 2010, 30(4): 347-360. DOI: 10.1097/WNO.0b013e3181e755af.
3. Laha B, Stafford BK, Huberman AD. Regenerating optic pathways from the eye to the brain. Science. 2017, 356(6342): 1031-1034. DOI: 10.1126/science.aal5060.
4. Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS?. Nat Rev Neurosci. 2008, 9(6): 481-493. DOI: 10.1038/nrn2398.
5. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006, 7(8): 617-627. DOI: 10.1038/ nrn1956.
6. Kurimoto T, Yin Y, Habboub G, et al. Neutrophils express oncomodulin and promote optic nerve regeneration. J Neurosci. 2013, 33(37): 14816-14824. DOI: 10.1523/ JNEUROSCI.5511-12.2013.
7. Sergeeva EG, Rosenberg PA, Benowitz LI. Non-cellautonomous regulation of optic nerve regeneration by amacrine cells. Front Cell Neurosci. 2021, 15: 666798. DOI: 10.3389/fncel.2021.666798.
8. Lee Y, Morrison BM, Li Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012, 487(7408): 443-448. DOI: 10.1038/nature11314.
9. Chen MS, Huber AB, van der Haar ME, et al. Nogo-a is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000, 403(6768): 434-439. DOI: 10.1038/35000219.
10. GrandPré T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 2002, 417(6888): 547-551. DOI: 10.1038/417547a.
11. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocytemyelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002, 417(6892): 941-944. DOI: 10.1038/nature00867.
12. Kottis V, Thibault P, Mikol D, et al. Oligodendrocytemyelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem. 2002, 82(6): 1566-1569. DOI: 10.1046/j.1471-4159.2002.01146.x.
13. Atwal JK, Pinkston-Gosse J, Syken J, et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science. 2008, 322(5903): 967-970. DOI: 10.1126/science.1161151.
14. Filbin MT. PirB, a second receptor for the myelin inhibitors of axonal regeneration Nogo66, MAG, and OMgp: implications for regeneration in vivo. Neuron. 2008, 60(5): 740-742. DOI: 10.1016/j.neuron.2008.12.001.
15. Domeniconi M, Cao Z, Spencer T, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 2002, 35(2): 283-290. DOI: 10.1016/s0896-6273(02)00770-5.
16. Liu BP, Fournier A, GrandPré T, et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 2002, 297(5584): 1190-1193. DOI: 10.1126/science.1073031.
17. Mi S, Lee X, Shao Z, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci. 2004, 7(3): 221-228. DOI: 10.1038/nn1188.
18. Wong ST, Henley JR, Kanning KC, et al. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci. 2002, 5(12): 1302-1308. DOI: 10.1038/nn975.
19. Venkatesh K, Chivatakarn O, Lee H, et al. The Nogo- 66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci. 2005, 25(4): 808-822. DOI: 10.1523/JNEUROSCI.4464-04.2005.
20. Lee JK, Geoffroy CG, Chan AF, et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron. 2010, 66(5): 663-670. DOI: 10.1016/j.neuron.2010.05.002.
21. Cafferty WBJ, Duffy P, Huebner E, et al. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci. 2010, 30(20): 6825-6837. DOI: 10.1523/ JNEUROSCI.6239-09.2010.
22. Vajda F, Jordi N, Dalkara D, et al. Cell type-specific Nogo-a gene ablation promotes axonal regeneration in the injured adult optic nerve. Cell Death Differ. 2015, 22(2): 323-335. DOI: 10.1038/cdd.2014.147.
23. Liebscher T, Schnell L, Schnell D, et al. Nogo-a antibody improves regeneration and locomotion of spinal cordinjured rats. Ann Neurol. 2005, 58(5): 706-719. DOI: 10.1002/ana.20627.
24. Merkler D, Metz GA, Raineteau O, et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci. 2001, 21(10): 3665-3673. DOI: 10.1523/JNEUROSCI.21-10-03665.2001.
25. Zheng B, Atwal J, Ho C, et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci U S A. 2005, 102(4): 1205-1210. DOI: 10.1073/ pnas.0409026102.
26. Dickendesher TL, Baldwin KT, Mironova YA, et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci. 2012, 15(5): 703-712. DOI: 10.1038/nn.3070.
27. Kawakami Y, Kurihara Y, Saito Y, et al. The soluble form of LOTUS inhibits nogo receptor-mediated signaling by interfering with the interaction between nogo receptor type 1 and p75 neurotrophin receptor. J Neurosci. 2018, 38(10):2589-2604. DOI: 10.1523/JNEUROSCI.0953-17.2018.
28. Kurihara Y, Takai T, Takei K. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B. J Neurochem. 2020, 155(3): 285-299. DOI: 10.1111/jnc.15013.
29. Su Y, Yu Z, Guo X, et al. Axonal regeneration of optic nerve after crush after PirBsiRNA transfection. Int J Clin Exp Pathol. 2017, 10(9): 9633-9638.
30. Yang M, Jian L, Fan W, et al. Axon regeneration after optic nerve injury in rats can be improved via PirB knockdown in the retina. Cell Biosci. 2021, 11(1): 158. DOI: 10.1186/ s13578-021-00670-w.
31. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32(12): 638-647. DOI: 10.1016/j.tins.2009.08.002.
32. Carulli D, Rhodes KE, Brown DJ, et al. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol. 2006, 494(4): 559-577. DOI: 10.1002/cne.20822.
33. De Winter F, Oudega M, Lankhorst AJ, et al. Injuryinduced class 3 semaphorin expression in the rat spinal cord. Exp Neurol. 2002, 175(1): 61-75. DOI: 10.1006/ exnr.2002.7884.
34. Kaneko S, Iwanami A, Nakamura M, et al. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med. 2006, 12(12): 1380-1389. DOI: 10.1038/nm1505.
35. Apostolova I, Irintchev A, Schachner M. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci. 2006, 26(30): 7849-7859. DOI: 10.1523/JNEUROSCI.1526-06.2006.
36. Shen Y, Tenney AP, Busch SA, et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science. 2009, 326(5952): 592- 596. DOI: 10.1126/science.1178310.
37. Torres-Vázquez J, Gitler AD, Fraser SD, et al. Semaphorinplexin signaling guides patterning of the developing vasculature. Dev Cell. 2004, 7(1): 117-123. DOI: 10.1016/ j.devcel.2004.06.008.
38. Andrews MR, Czvitkovich S, Dassie E, et al. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci. 2009, 29(17): 5546-5557. DOI: 10.1523/ JNEUROSCI.0759-09.2009.
39. Wang X, Hasan O, Arzeno A, et al. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp Neurol. 2012, 237(1): 55-69. DOI: 10.1016/ j.expneurol.2012.06.009.
40. Sapieha PS, Duplan L, Uetani N, et al. Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol Cell Neurosci. 2005, 28(4): 625- 635. DOI: 10.1016/j.mcn.2004.10.011.
41.  Shirvan A, Kimron M, Holdengreber V, et al. Antisemaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J Biol Chem. 2002, 277(51): 49799-49807. DOI: 10.1074/jbc. M204793200.
42. Han F, Huo Y, Huang CJ, et al. MicroRNA-30b promotes axon outgrowth of retinal ganglion cells by inhibiting Semaphorin3A expression. Brain Res. 2015, 1611: 65-73. DOI: 10.1016/j.brainres.2015.03.014.
43. Schreiber J, Schachner M, Schumacher U, et al. Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice. Acta Histochem. 2013, 115(8): 865-878. DOI: 10.1016/ j.acthis.2013.04.009.
44. Chen J, Joon Lee H, Jakovcevski I, et al. The extracellular matrix glycoprotein tenascin-C is beneficial for spinal cord regeneration. Mol Ther. 2010, 18(10): 1769-1777. DOI:10.1038/mt.2010.133.
45. Cheah M, Andrews MR, Chew DJ, et al. Expression of an activated integrin promotes long-distance sensory axon regeneration in the spinal cord. J Neurosci. 2016, 36(27): 7283-7297. DOI: 10.1523/JNEUROSCI.0901-16.2016.
46. Jin X, Yamashita T. Microglia in central nervous system repair after injury. J Biochem. 2016, 159(5): 491-496. DOI: 10.1093/jb/mvw009.
47. Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014, 15(5): 300-312. DOI: 10.1038/ nrn3722.
48. Elmore MRP, Najafi AR, Koike MA, et al. Colonystimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014, 82(2): 380-397. DOI: 10.1016/j.neuron.2014.02.040.
49. Hilla AM, Diekmann H, Fischer D. Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury. J Neurosci. 2017, 37(25): 6113-6124. DOI: 10.1523/JNEUROSCI.0584-17.2017.
50.  Leon S, Yin Y, Nguyen J, et al. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci. 2000, 20(12): 4615-4626. DOI: 10.1523/ JNEUROSCI.20-12-04615.2000.
51. Yin Y, Cui Q, Li Y, et al. Macrophage-derived f a c t o r s s t i m u l a t e o p t i c n e r v e r e g e n e r a t i o n . J Neurosci. 2003, 23(6): 2284-2293. DOI: 10.1523/ JNEUROSCI.23-06-02284.2003.
52. David S, Bouchard C, Tsatas O, et al. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron. 1990, 5(4): 463-469. DOI: 10.1016/0896-6273(90)90085-t.
53. Li Y, Irwin N, Yin Y, et al. Axon regeneration in goldfish and rat retinal ganglion cells: differential responsiveness to carbohydrates and cAMP. J Neurosci. 2003, 23(21): 7830-7838. DOI: 10.1523/JNEUROSCI.23-21-07830.2003.
54. Yin Y, Cui Q, Gilbert HY, et al. Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci USA. 2009, 106(46): 19587-19592. DOI: 10.1073/ pnas.0907085106.
55. Kurimoto T, Yin Y, Omura K, et al. Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J Neurosci. 2010, 30(46): 15654-15663. DOI: 10.1523/ JNEUROSCI.4340-10.2010.
56. Xie L, Yin Y, Jayakar S, et al. The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC-derived sensory neurons. Sci Transl Med. 2023, 15(708): eadg6241. DOI: 10.1126/scitranslmed.adg6241.
57. B a l d w i n K T, C a r b a j a l K S , S e g a l B M , e t a l . Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration. Proc Natl Acad Sci USA. 2015, 112(8): 2581-2586. DOI: 10.1073/ pnas.1423221112.
58. Xie L, Yin Y, Benowitz L. Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy. Proc Natl Acad Sci USA. 2021, 118(9): e2017282118. DOI: 10.1073/ pnas.2017282118.
59. Sas AR, Carbajal KS, Jerome AD, et al. A new neutrophil subset promotes CNS neuron survival and axon regeneration. Nat Immunol. 2020, 21(12): 1496-1505. DOI: 10.1038/s41590-020-00813-0.
60. Jerome AD, Sas AR, Wang Y, et al. Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration. Nat Immunol. 2024, 25(6): 957-968. DOI: 10.1038/s41590-024-01836-7.
61. Passino R, Finneran MC, Hafner H, et al. Neutrophilinflicted vasculature damage suppresses immune-mediated optic nerve regeneration. Cell Rep. 2024, 43(3): 113931.DOI: 10.1016/j.celrep.2024.113931.
62. Hilla AM, Baehr A, Leibinger M, et al. CXCR4/ CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration. Proc Natl Acad Sci USA. 2021, 118(21): e2016409118. DOI: 10.1073/ pnas.2016409118.
63. Xie L, Cen LP, Li Y, et al. Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells' response to Pten deletion. Proc Natl Acad Sci USA. 2022, 119(15): e2113751119. DOI: 10.1073/ pnas.2113751119.
64. u H, Shen B, Han R, et al. CX3CL1-CX3CR1 axis protects retinal ganglion cells by inhibiting microglia activation in a distal optic nerve trauma model. Inflamm Regen. 2024, 44(1): 30. DOI: 10.1186/s41232-024-00343- 4.
65.  Zhang ZY, Zuo ZY, Liang Y, et al. Promotion of axon regeneration and protection on injured retinal ganglion cells by rCXCL2. Inflamm Regen. 2023, 43(1): 31. DOI: 10.1186/s41232-023-00283-5.
66. L e i b i n g e r M , M ü l l e r A , A n d r e a d a k i A , e t a l . Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci. 2009, 29(45): 14334-14341. DOI: 10.1523/JNEUROSCI.2770-09.2009.
67. Smith PD, Sun F, Park KK, et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron. 2009, 64(5): 617-623. DOI: 10.1016/j.neuron.2009.11.021.
68. Wang D, Luo M, Huang B, et al. Localized co-delivery of CNTF and FK506 using a thermosensitive hydrogel for retina ganglion cells protection after traumatic optic nerve injury. Drug Deliv. 2020, 27(1): 556-564. DOI: 10.1080/10717544.2020.1748759.
69. Pernet V, Di Polo A. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain. 2006, 129(Pt 4): 1014-1026. DOI: 10.1093/ brain/awl015.
70. Diamond JS. Inhibitory interneurons in the retina: types, circuitry, and function. Annu Rev Vis Sci. 2017, 3: 1-24. DOI: 10.1146/annurev-vision-102016-061345.
71. Tran NM, Shekhar K, Whitney IE, et al. Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes. Neuron. 2019, 104(6): 1039-1055.e12. DOI: 10.1016/j.neuron.2019.11.006.
72. Lee S, Chen L, Chen M, et al. An unconventional glutamatergic circuit in the retina formed by vGluT3 amacrine cells. Neuron, 2014, 84(4): 708-715. DOI: 10.1016/j.neuron.2014.10.021.
73. Goldberg JL, Klassen MP, Hua Y, et al. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science. 2002, 296(5574): 1860-1864. DOI: 10.1126/science.1068428.
74. Kunzevitzky NJ, Almeida MV, Duan Y, et al. Foxn4 is required for retinal ganglion cell distal axon patterning. Mol Cell Neurosci. 2011, 46(4): 731-741. DOI: 10.1016/ j.mcn.2011.02.004.
75. Li Y, Andereggen L, Yuki K, et al. Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration. Proc Natl Acad Sci USA, 2017, 114(2): E209-E218. DOI: 10.1073/pnas.1616811114.
76. Trakhtenberg EF, Li Y, Feng Q, et al. Zinc chelation and Klf9 knockdown cooperatively promote axon regeneration after optic nerve injury. Exp Neurol. 2018, 300: 22-29. DOI: 10.1016/j.expneurol.2017.10.025.
77. Zhang Y, Williams PR, Jacobi A, et al. Elevating growth factor responsiveness and axon regeneration by modulating presynaptic inputs. Neuron. 2019, 103(1): 39-51.e5. DOI: 10.1016/j.neuron.2019.04.033.
78. Zhang Q, Xue J, Tang J, et al. Modulating amacrine cell-derived dopamine signaling promotes optic nerve regeneration and preserves visual function. Sci Adv. 2024, 10(31): eado0866. DOI: 10.1126/sciadv.ado0866.
79. Beckers A, Moons L. Dendritic shrinkage after injury: a cellular killer or a necessity for axonal regeneration?. Neural Regen Res. 2019, 14(8): 1313-1316. DOI: 10.4103/1673-5374.253505.
80. Beckers A, Van Dyck A, Bollaerts I, et al. An antagonistic axon-dendrite interplay enables efficient neuronal repair in the adult zebrafish central nervous system. Mol Neurobiol. 2019, 56(5): 3175-3192. DOI: 10.1007/s12035-018-1292- 5.
81. Cui Q, Yip HK, Zhao RCH, et al. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci. 2003, 22(1): 49-61. DOI: 10.1016/s1044- 7431(02)00037-4.
82. Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci. 2003, 23(4): 1416-1423. DOI: 10.1523/ JNEUROSCI.23-04-01416.2003.
83. Drummond ES, Rodger J, Penrose M, et al. Effects of intravitreal injection of a Rho-GTPase inhibitor (BA- 210), or CNTF combined with an analogue of cAMP, on the dendritic morphology of regenerating retinal ganglion cells. Restor Neurol Neurosci. 2014, 32(3): 391-402. DOI: 10.3233/RNN-130360.
84. Francis MM, Freeman MR. Dendrites actively restrain axon outgrowth and regeneration. Proc Natl Acad Sci USA. 2016, 113(20): 5465-5466. DOI: 10.1073/ pnas.1605215113.
85. Chung SH, Awal MR, Shay J, et al. Novel DLKindependent neuronal regeneration in Caenorhabditis elegans shares links with activity-dependent ectopic outgrowth. Proc Natl Acad Sci USA. 2016, 113(20): E2852-E2860. DOI: 10.1073/pnas.1600564113.
86. Suzuki S, Tachibana M, Kaneko A. Effects of glycine and GABA on isolated bipolar cells of the mouse retina. J Physiol. 1990, 421: 645-662. DOI: 10.1113/jphysiol.1990. sp017967.
87. Panter SS, Yum SW, Faden AI. Alteration in extracellular amino acids after traumatic spinal cord injury. Ann Neurol. 1990, 27(1): 96-99. DOI: 10.1002/ana.410270115.
88. Xu GY, Hughes MG, Ye Z, et al. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp Neurol. 2004, 187(2): 329-336. DOI: 10.1016/j.expneurol.2004.01.029.
89. Romaus-Sanjurjo D, Ledo-García R, Fernández-López B, et al. GABA promotes survival and axonal regeneration in identifiable descending neurons after spinal cord injury in larval lampreys. Cell Death Dis. 2018, 9(6): 663. DOI: 10.1038/s41419-018-0704-9.
90. Goldberg JL, Espinosa JS, Xu Y, et al. Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity. Neuron. 2002, 33(5): 689-702. DOI: 10.1016/s0896- 6273(02)00602-5.
91. Li S, Yang C, Zhang L, et al. Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling. Proc Natl Acad Sci USA. 2016, 113(7): 1937- 1942. DOI: 10.1073/pnas.1523645113.
92. Lim JH A, Stafford BK, Nguyen PL, et al. Neural activity promotes long-distance, target-specific regeneration of adult retinal axons. Nat Neurosci. 2016, 19(8): 1073-1084. DOI: 10.1038/nn.4340.
93. de Lima S, Koriyama Y, Kurimoto T, et al. Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. Proc Natl Acad Sci USA. 2012, 109(23): 9149-9154. DOI: 10.1073/ pnas.1119449109.
94. West AE, Greenberg ME. Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb Perspect Biol. 2011, 3(6): a005744. DOI: 10.1101/cshperspect.a005744.
95. Yap EL, Greenberg ME. Activity-regulated transcription: bridging the gap between neural activity and behavior. Neuron. 2018, 100(2): 330-348. DOI: 10.1016/ j.neuron.2018.10.013.
96. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996, 36(18): 2979-2994. DOI: 10.1016/0042-6989(96)00017-x.
97. Aras MA, Aizenman E. Redox regulation of intracellular zinc: molecular signaling in the life and death of neurons. Antioxid Redox Signal. 2011, 15(8): 2249-2263. DOI: 10.1089/ars.2010.3607.
98. Spahl DU, Berendji-Grün D, Suschek CV, et al. Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release. Proc Natl Acad Sci USA. 2003, 100(24): 13952-13957. DOI: 10.1073/pnas.2335190100.

相关文章

Zanmei Hua;Qiuyun Fang;Xiangyin Sha;Ruiming Yang;Zuopeng Hong,Role of Retinal Nerve Fiber Layer Thickness and Optic Disk Measurement by OCT on Early Diagnosis of Glaucoma陈利群;易湘龙,A review of corneal nerve and limbal stem cellCancan Lv;Wei Xiao ,Clinical Analysis of the Incidence and the Treatment of Pediatric Cataract Patients with Optic-nerve Maldevelopment